Next Article in Journal
CSF1R Inhibition Combined with GM-CSF Reprograms Macrophages and Disrupts Protumoral Interplays with AML Cells
Next Article in Special Issue
The Hepatic Sinusoid in Chronic Liver Disease: The Optimal Milieu for Cancer
Previous Article in Journal
Risk, Characteristics and Biomarkers of Cytokine Release Syndrome in Patients with Relapsed/Refractory AML or MDS Treated with CD3xCD123 Bispecific Antibody APVO436
Previous Article in Special Issue
Hepatocyte Polyploidy: Driver or Gatekeeper of Chronic Liver Diseases
 
 
Article

Article Versions Notes

Cancers 2021, 13(21), 5282; https://doi.org/10.3390/cancers13215282
Action Date Notes Link
article xml file uploaded 21 October 2021 14:44 CEST Original file -
article xml uploaded. 21 October 2021 14:44 CEST Update https://www.mdpi.com/2072-6694/13/21/5282/xml
article pdf uploaded. 21 October 2021 14:44 CEST Version of Record https://www.mdpi.com/2072-6694/13/21/5282/pdf
article html file updated 21 October 2021 14:46 CEST Original file -
article html file updated 30 July 2022 12:19 CEST Update https://www.mdpi.com/2072-6694/13/21/5282/html
Back to TopTop